Latest Breaking News On - Autistic spectrum disorder deficits - Page 1 : comparemela.com

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX), a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative.

Daniel alkonRobert weinsteinAlan tuchmanNemoursai dupontExchange commissionDrug administrationSynaptogenix incCleveland clinicChief scientificOrphan drug designationPrivate securities litigation reform actAutistic spectrum disorder deficitsMedia contacts

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX), a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative.

Daniel alkonRobert weinsteinAlan tuchmanNemoursai dupontExchange commissionDrug administrationSynaptogenix incCleveland clinicChief scientificOrphan drug designationPrivate securities litigation reform actAutistic spectrum disorder deficitsMedia contacts

Synaptogenix Announces Participation at the Benzinga Healthcare Small Cap Conference

Synaptogenix Announces Participation at the Benzinga Healthcare Small Cap Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Daniell alkonRobert weinsteinBrett maasExchange commissionSynaptogenix inc nasdaqDrug administrationSynaptogenix incBenzinga healthcare small cap conferenceChief scientific officerOrphan drug designationBenzinga small cap conferenceSmall capEducational modulesAutistic spectrum disorder deficits

Synaptogenix Announces Participation at the H C Wainwright 23rd Annual Global Investment Conference

Synaptogenix Announces Participation at the H C Wainwright 23rd Annual Global Investment Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Daniel alkonRobert weinsteinBrett maasExchange commissionPrnewswire synaptogenix inc nasdaqDrug administrationHc wainwright coSagient research systemsSynaptogenix incAnnual global investment virtualChief scientific officerOrphan drug designationAutistic spectrum disorder deficits